BioSpace News Archive

Gilead Sciences, Inc. announced new data to be presented at the European Association for the Study of the Liver Congress 2023, June 21-24, 2023.

Vivani Medical, Inc. announced that Company CEO Adam Mendelsohn, Ph.D. has been invited to participate at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest.

Caris Life Sciences®, the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, announced that SWOG Cancer Research Network has joined the Caris Precision Oncology Alliance™.

IO Biotech (Nasdaq: IOBT) announced today that it has randomized 225 patients in its global Phase 3 clinical trial for IO102-IO103, in combination with KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in patients with advanced melanoma.

SeaStar Medical Holding Corporation, a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that Eric Schlorff, CEO, will present at the Maxim Group Virtual Healthcare Conference hosted by M-Vest on Wednesday, June 21 at 2:30 p.m. Eastern time.

DermTech, Inc. announced that ECRI completed its evaluation of the Pigmented Lesion Assay, the foundational assay for the DermTech Melanoma Test, and changed its rating from ‘Inconclusive’ to ‘Somewhat Favorable’.

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced the 505(b)(2) New Drug Application (NDA) approval from the U.S. Food and Drug Administration (“FDA”) for PEMRYDI RTU®.

Hoth Therapeutics, Inc. (NASDAQ: HOTH) today announced today that it has received written approval from the University of Texas MD Anderson Cancer Center Institutional Review Board (IRB) to proceed with its First-in-Human (FIH) Phase 2a clinical trial of HT-001 for the treatment of skin toxicities associated with Epidermal Growth Factor Receptor Inhibitors (EGFRi).

When Vicky Choi began her career as an engineer, she noticed that women and Asian people overall were well represented in the field - but that Asian women weren’t reflected in upper management and leadership positions.

Biodexa Pharmaceuticals PLC announces that at its Annual General Meeting and subsequent General Meeting held earlier , all resolutions put to the Company’s shareholders were duly passed.